Earnings calendar/CRNX
Crinetics Pharmaceuticals, Inc. (CRNX)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-1.20
Street estimate
Revenue target
$21.0M
Street estimate
Trailing EPS (avg 4Q)
$-1.26
Beat rate last 4: 50%
Latest EPS YoY
+7.3%
vs 2025-08-07
Latest revenue YoY
+2336.3%
How results look so far
Trailing revenue (avg 4Q)
$10.5M
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 3, 2026
EPS beat
EPS actual / est
$-1.14 / $-1.18
+3.4%
Revenue actual / est
$25.1M / $14.8M
+69.2%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-1.20 | Pending | — | $21.0M | Pending | — |
| 8/3/2026 | $-1.18 | $-1.14 | +3.4% | $14.8M | $25.1M | +69.2% |
| 5/14/2026upcoming | $-1.20 | Pending | — | $8.5M | Pending | — |
| 5/7/2026 | $-1.22 | $-1.23 | -0.8% | $8.5M | $10.7M | +26.1% |
| 2/26/2026 | $-1.37 | $-1.29 | +5.8% | $4.5M | $6.2M | +37.2% |
| 11/6/2025 | $-1.27 | $-1.38 | -8.7% | $4.3M | $143,000 | -96.7% |
| 8/7/2025 | $-1.13 | $-1.23 | -8.8% | $394,000 | $1.0M | +161.7% |
| 5/8/2025 | $-0.99 | $-1.04 | -5.1% | $347,910 | $361,000 | +3.8% |
| 2/27/2025 | $-0.92 | $-0.88 | +4.3% | $727,270 | Pending | — |
| 11/12/2024 | $-0.91 | $-0.96 | -5.4% | $218,091 | Pending | — |
| 8/8/2024 | $-0.86 | $-0.94 | -9.3% | $510,000 | $399,000 | -21.8% |
| 5/9/2024 | $-0.84 | $-0.93 | -10.7% | $260,000 | $640,000 | +146.2% |
| 2/28/2024 | $-0.89 | $-0.90 | -1.1% | $260,000 | Pending | — |
| 11/7/2023 | $-0.89 | $-1.01 | -13.5% | $190,000 | $346,000 | +82.1% |
| 8/8/2023 | $-0.85 | $-0.94 | -10.6% | $140,000 | $988,000 | +605.7% |
| 5/4/2023 | $-0.82 | $-0.85 | -3.7% | $630,000 | $2.7M | +325.2% |
| 2/28/2023 | $-0.82 | $-0.84 | -2.4% | $250,000 | $709,000 | +183.6% |
| 11/14/2022 | $-0.78 | $-0.78 | 0.0% | $250,000 | $458,000 | +83.2% |
| 8/12/2022 | $-0.62 | $-0.81 | -30.6% | $600,000 | $439,000 | -26.8% |
| 5/12/2022 | $-0.56 | $-0.73 | -30.4% | $5.2M | $3.1M | -39.8% |
| 3/30/2022 | $-0.57 | $-0.68 | -19.3% | — | $1.1M | — |
| 11/5/2021 | $-0.70 | $-0.73 | -4.3% | — | Pending | — |
| 8/10/2021 | $-0.60 | $-0.70 | -16.7% | — | Pending | — |
| 5/6/2021 | $-0.65 | $-0.69 | -6.2% | — | Pending | — |
| 3/30/2021 | $-0.58 | $-0.66 | -13.8% | — | $0 | — |
| 11/6/2020 | $-0.52 | $-0.56 | -7.7% | — | $0 | — |
| 8/7/2020 | $-0.52 | $-0.53 | -1.9% | $76,358.49 | Pending | — |
| 5/8/2020 | $-0.63 | $-0.71 | -12.7% | $63,000 | $71,000 | +12.7% |
| 3/9/2020 | $-0.67 | $-0.60 | +10.4% | $363,800 | $321,000 | -11.8% |
| 11/12/2019 | $-0.54 | $-0.60 | -11.1% | $479,750 | $505,000 | +5.3% |
| 8/13/2019 | $-0.45 | $-0.51 | -13.3% | $331,019.61 | Pending | — |
| 5/13/2019 | $-0.39 | $-0.37 | +5.1% | $406,675.68 | $367,000 | -9.8% |
| 3/13/2019 | $-0.39 | $-0.35 | +10.3% | $914,885.71 | $781,000 | -14.6% |
| 11/13/2018 | $-0.34 | $-0.38 | -11.8% | $490,315.79 | $548,000 | +11.8% |
| 8/30/2018 | $-0.29 | $-2.41 | -731.0% | $3.7M | $657,000 | -82.4% |
| 7/18/2018 | — | $-0.25 | — | — | $442,000 | — |
| 12/31/2017 | — | $-0.18 | — | — | $528,000 | — |
| 9/30/2017 | — | $-0.17 | — | — | $640,000 | — |
| 6/30/2017 | — | $-0.12 | — | — | $832,000 | — |
| 3/31/2017 | — | $-0.19 | — | — | $45,000 | — |